Medicine and Dentistry
Patient
100%
B-Cell Chronic Lymphocytic Leukemia
52%
Donor
39%
Myelodysplastic Syndrome
31%
Transplantation
30%
Therapeutic Procedure
26%
Reduced Intensity Conditioning
26%
Leukemia Cell
25%
Acute Myeloid Leukemia
20%
Disease
17%
Allogeneic Hematopoietic Stem Cell Transplantation
16%
Follicular Lymphoma
15%
Follow up
15%
Volunteer
15%
Donor Lymphocyte Infusion
13%
Spontaneous Remission
13%
Toxicity
12%
Stem Cell Therapy
12%
Engraftment
11%
Antiapoptotic
11%
Lymphoproliferative Disease
11%
T Cell
10%
Vascular Endothelium
10%
Allogeneic Stem Cell Transplantation
10%
Rituximab
10%
Hematopoietic Stem Cell Transplantation
10%
Sibling
9%
Microenvironment
8%
Diagnosis
8%
B Cell
7%
Analysis
7%
Fludarabine
7%
Overall Survival
7%
Neoplasm
7%
Cells
6%
Prognosis
6%
Hematopoietic Cell
6%
Outpatient
6%
Bone Marrow Transplantation
6%
Allograft
6%
Hematologic Malignancy
6%
Guanosine Triphosphatase
5%
Oncology
5%
Infection
5%
Adult
5%
Neutropenia
5%
Endothelial Cell
5%
Chemotherapy
5%
Gemcitabine
5%
Paraneoplastic Pemphigus
5%
Immunology and Microbiology
Leukemia Cell
58%
Graft-Versus-Host Disease
35%
B Cell
22%
Transplant Procedure
22%
Engraftment
18%
Dendritic Cell
10%
Vascular Endothelium
10%
Bone Marrow
6%
T Cell Activation
6%
T Cell Proliferation
5%
Monocyte
5%
C-C Chemokine Receptor Type 7
5%
Viral Load
5%
Macrophage Inflammatory Protein
5%
Lymphoid Tissue
5%
